loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: Linosept

    Menu

    Linosept

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 667Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 21131 / DOSAGE - SOLUTION;INTRAVENOUS - 400MG/200ML (2MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    LINEZOLID(UNII: ISQ9I6J12J)
    (LINEZOLID - UNII:ISQ9I6J12J)     		LINEZOLID600mg in 300

    Inactive Ingredients

    Ingredient Name
    Fresenius Kabi Norge As
    CITRIC ACID MONOHYDRATE(2968PHW8QP)
    DEXTROSE, UNSPECIFIED FORM(IY9XDZ35W2)
    SODIUM CITRATE, UNSPECIFIED FORM(1Q73Q2JULR)